Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03028857 : Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal
PhasePhase 1
AgesMin: 18 Years Max: 45 Years
Eligibility
Inclusion Criteria:

- General Health: Other than pregnancy related illnesses, physically healthy expectant
mothers

- ages 18-45 years

- prepregnancy BMI>18 and <45

Exclusion Criteria:

- Prior history of fetal death

- Maternal use of more than 1 drink per day of alcohol

- Maternal use of illicit drugs, not including cannabis

- Maternal chronic chronic steroid use

- Current personal history of

1. Chronic neurological illness, including Parkinson's

2. Chronic infections, including HIV

3. Suicidal ideation

- Current personal or family history out to first degree relatives of

1. Trimethylaminuria

2. Homocystinuria

- Primary language other than English or Spanish

- Evidence of noncompliance

- Use of supplements other than a standard daily multivitamin such as

1. a prenatal vitamin and/or

2. omega-3 fatty acid supplement.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03028857      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740